Funding to support work on atropine auto-injectors in 0.5 mg, 1 mg, and 2 mg strengths, which are used for rapid treatment of certain poisonings (such as organophosphate/nerve agent exposure). Suitable for organizations that can develop, manufacture, test, or supply these devices to strengthen emergency and public health preparedness.